Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|September 1, 2024
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY)Vahid Shaygannejad, Fereshteh Ashtari, Morteza Saeidi, et al.Scientific Reports|October 22, 2024
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trialMohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, et al.Current Journal of Neurology|November 27, 2023
Iranian specialists' approach to surgery in patients with multiple sclerosisFereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh, et al.Current Journal of Neurology|November 27, 2023
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairmentFereshteh Ghadiri, Elnaz Asadollahzadeh, Zahra Ebadi, et al.European Journal of Neurology|November 23, 2021
Dural arteriovenous fistulas in cerebral venous thrombosis: Data from the International Cerebral Venous Thrombosis Consortium: Data from the International Cerebral Venous Thrombosis ConsortiumErik Lindgren, Alexandros Rentzos, Sini Hiltunen, et al.Neurology|September 2, 2025
Mortality After Cerebral Venous ThrombosisElisa Häppölä, Sini Hiltunen, Erik Lindgren, et al.Neurology|August 8, 2020
Late seizures in cerebral venous thrombosisMayte Sánchez van Kammen, Erik Lindgren, Suzanne M Silvis, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 29, 2026
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivityRoya Abolfazli, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.Neurology|August 8, 2020
Acute symptomatic seizures in cerebral venous thrombosisErik Lindgren, Suzanne M Silvis, Sini Hiltunen, et al.European Journal of Neurology|May 11, 2023
A scoring tool to predict mortality and dependency after cerebral venous thrombosisErik Lindgren, Katarzyna Krzywicka, Maria A de Winter, et al.Pageof 5